Stay updated on Daratumumab & DLI for Relapsed AML Clinical Trial

Sign up to get notified when there's something new on the Daratumumab & DLI for Relapsed AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab & DLI for Relapsed AML Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing v3.6.0, indicating an internal update to the page framework; no study content or visible details appear to be affected.
    Difference
    0.1%
    Check dated 2026-06-30T02:12:10.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label formatting, while also displaying a new revision tag (v3.6.0) and noting that recruitment is no longer open.
    Difference
    0.5%
    Check dated 2026-06-15T22:21:19.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.5.4 to v3.5.5. This indicates a minor deployment update and does not modify the study details or other user-facing content.
    Difference
    0.1%
    Check dated 2026-06-08T17:37:45.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.5.4, indicating a new software revision was applied. The previous revision v3.5.3 was removed.
    Difference
    0.1%
    Check dated 2026-05-18T03:56:13.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    The page’s release/version marker was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a ClinicalTrials.gov site revision without changing the underlying study details.
    Difference
    0.1%
    Check dated 2026-04-26T15:22:41.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2; no user-facing content changes are evident.
    Difference
    0.1%
    Check dated 2026-04-19T13:38:20.000Z thumbnail image

Stay in the know with updates to Daratumumab & DLI for Relapsed AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab & DLI for Relapsed AML Clinical Trial page.